Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes

Table 1

Key demographic characteristics and hepatitis coinfection prevalence rates of participants in Yuxi, China, stratified by delayed testers and nondelayed testers.

	Total	Delayed testers	Nondelayed testers	value
Demographic characteristics	1663 (100%)	348 (20.9%)	1315 (79.1%)
Gender				0.02
Female	661 (39.7%)	120 (18.2%)	541 (81.8%)
Male	1002 (60.3%)	228 (22.8%)	774 (77.2%)
Age (IQR)	36 (30–45)	42 (34–50)	35 (30–43)	<0.01
BMI (IQR)	21.3 (19.3–23.1)	19.1 (17.4–20.8)	21.4 (19.5–23.2)	<0.01
Marriage status				0.04
Married	1156 (69.5%)	263 (22.8%)	893 (77.2%)
Single	261 (15.7%)	41 (15.7%)	220 (84.3%)
Divorced	181 (10.9%)	36 (19.9%)	145 (80.1%)
Widowed	62 (3.7%)	8 (12.9%)	54 (87.1%)
Unknown	3 (0.2%)	0 (0%)	3 (100%)
Transmission route				<0.01
Heterosexuals	1158 (69.6%)	265 (22.9%)	893 (77.1%)
IDU	352 (21.2%)	39 (11.1%)	313 (88.9%)
Homosexuals	46 (2.8%)	9 (19.6%)	37 (80.4%)
FPD	9 (0.5%)	2 (22.2%)	7 (77.8%)
Unknown	98 (5.9%)	33 (33.7%)	65 (66.3%)
ART initiation year				0.04
2004–2006	19 (1.1%)	7 (36.8%)	12 (63.2%)
2007–2009	218 (13.1%)	53 (24.3%)	165 (75.7%)
2010–2012	602 (36.2%)	139 (23.1%)	463 (76.9%)
2013–2015	796 (47.9%)	149 (18.7%)	647 (81.3%)
Unknown	28 (1.7%)	0 (0%)	28 (100%)
CD4 counts at ART initiation				<0.01
0–200	513 (30.8%)	339 (66.1%)	174 (33.9%)
200–350	641 (38.5%)	8 (0.4%)	633 (96.4%)
350–500	258 (15.5%)	1 (0.1%)	257 (99.9%)
>500	251 (15.1%)	0 (0%)	251 (100%)
Hepatitis coinfection
HCV coinfection				<0.001
Positive	253 (15.2%)	28 (11.7%)	225 (24.7%)
Negative	897 (53.9%)	212 (88.3%)	685 (76.3%)
HBV coinfection				0.76
Positive	82 (4.9%)	18 (6.8%)	64 (6.3%)
Negative	1193 (71.7%)	245 (93.2%)	948 (93.7%)